AGENTS D'INTERRUPTION VASCULAIRE ET UTILISATIONS ASSOCIEES
- 专利权人:
- GENENTECH; INC.
- 发明人:
- ASHKENAZI, AVI J.
- 申请号：
- CA2834776
- 公开号：
- CA2834776A1
- 申请日:
- 2012.05.02
- 申请国别(地区):
- CA
- 年份:
- 2012
- 代理人:
- 摘要：
- Uses of Apo2L/TRAIL polypeptides and death receptor agonist antibodies to disrupt tumor associated vasculature are provided. Methods of treating cancer in mammals, kits, and articles of manufacture are also provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- VASCULAR DISRUPTION AGENTS AND USES THEREOF
- METHODS OF USING DEATH RECEPTOR AGONISTS AND EGFR INHIBITORS
- Methods of using death receptor agonists and EGFR inhibitors
- ANTIBODY SELECTIVE FOR A TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND RECEPTOR AND USES THEREOF
- Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
